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The ‘Vienna consensus’ stifles progress on UN drug policy 
 
Statement from the International Drug Policy Consortium 
 
14 March 2019, VIENNA – The International Drug Policy Consortium (IDPC), a global network of more than 
180 NGOs that come together to promote drug policies that are based on human rights, human security, social 
inclusion and public health, express our disappointment with, and concerns about, the Ministerial Declaration 
‘Strengthening our actions at the national, regional and international levels to accelerate the implementation 
of our joint commitments to address and counter the world drug problem’, adopted today in Vienna by the 
United Nations. 
 
While we acknowledge that the statement represents limited progress in some areas, we regret that it repeats 
the mistakes of the past and was negotiated in the absence of a genuine and honest evaluation of the past 
decade, since the adoption of the 2009 Political Declaration and Action Plan on Drugs. We note that several 
progressive member states negotiated hard for stronger language on human rights and sought to avoid 
restating the damaging ‘drug-free goals’ that have plagued UN drug policy documents for decades. 
Unfortunately, the so-called ‘Vienna consensus’ won out and has once again stifled progress in UN drug policy. 
 
In the lead up to this Ministerial Segment, IDPC called repeatedly on Member States to formally and honestly 
evaluate progress made towards the overarching goal, in the 2009 Political Declaration, to significantly reduce 
or eliminate the illicit drug market, as well as in the implementation of the UNGASS Outcome Document. 
Unfortunately, a formal and comprehensive review of the past decade of drug policies was not conducted by 
governments or the UNODC. The lack of appetite for a formal review illustrates the fact that governments are 
still unable to accept that decades of attempting to eradicate the global illicit drug market through punitive 
and repressive measures have failed.  
 
In the void left by the lack of such a review, IDPC 
produced a civil society ‘shadow report’ titled 
Taking stock: A decade of drug policy which 
clearly demonstrates the impossibility of 
credibly claiming any progress made to date, 
given that the illicit drug market is larger and 
more robust than ever before, while drug-
related and devastating policy harms are on the 
rise. Ten years ago, the previous UNODC 
Executive Director, Mr. Costa referred to the 
‘unintended negative consequences’ of drug 
control as part of the previous 10-year review – 
that paper is unfortunately still starkly relevant 
today.  
 
Ahead of the 2019 Ministerial Segment, the 
IDPC network had developed four policy 
recommendations which remain relevant for 
our assessment of the Ministerial Declaration 
adopted today. 
 
Firstly, the IDPC network had recommended 
that the international community finally move away from the ‘drug-free world’ targets given the devastating 
The devastating impacts of repressive drug control in 
the past decade 
 
• A 60% increase in drug-related deaths between 2000 and 
2015, with a harrowing 450,000 deaths in 2015. 
• At least 3,940 people executed for a drug offence over 
the last decade, with 33 jurisdictions retaining the death 
penalty for drug offences in violation of international 
standards. 
• Around 27,000 extrajudicial killings in drug crackdowns in 
the Philippines. 
• More than 71,000 overdose deaths in the United States 
in 2017 alone. 
• A global pain epidemic, resulting from restrictions in 
access to controlled medicines, which have left 75% of 
the world’s population without proper access to pain 
relief. 
• Mass incarceration fuelled by the criminalisation of 
people who use drugs – with 1 in 5 prisoners incarcerated 
for drug offences, mostly for possession for personal use. 
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impacts that efforts to achieve a drug-free society have produced over the past decade on human rights, 
health and wellbeing. This goal is not ‘aspirational’ – as would calling for a world free of HIV or poverty. It is 
devastating for communities worldwide. 
 
Despite the welcome and unprecedented acknowledgement of the scale of the ‘persistent and emerging 
challenges’ identified in the Declaration, it is unfortunate that the document commits member states to once 
again ‘work towards the elimination’ of cultivation, production, trafficking and use, and reiterates the goal of 
‘actively promoting a society free of drug abuse’. The final text also includes a commitment to accelerate the 
achievement of all ‘aspirational goals’ of 2009, 2014 and 2016 – meaning that the eradication goals included 
in the 2009 Political Declaration are implicitly restated.  
 
But striving towards all ‘aspirational goals’ made in the past decade also means that member states could 
choose to turn instead towards those goals included in the UNGASS Outcome Document, and indirectly, the 
Sustainable Development Goals, which are mentioned in the 2016 document. In the coming decade, therefore, 
it is our hope that drug policy can prioritise the operationalisation of UNGASS recommendations and the 
achievement of the 2030 Agenda for Sustainable Development, in close partnership with civil society. This will 
require the adoption of a revised Annual Reports Questionnaire (ARQ) that adequately reflects the new 
thematic chapters of the UNGASS, in order to track progress against the human rights, development and 
health aspects of drug policy. Efforts to improve data collection on drug policy should nonetheless not limit 
themselves to the ARQ, and make better use of additional data collected by civil society, academia and other 
UN agencies, in particular on human rights considerations.  
 
Secondly, and in an effort to ensure UN system-wide coherence in addressing drug issues globally, we had 
recommended that Member States use this opportunity to meaningfully reflect upon how drug policies 
contribute to the wider UN goals of promoting health, human rights, development, and peace and security. 
International human rights obligations and the Sustainable Development Goals provide a framework to guide 
the implementation and development of all policies and programmes.  
 
In this context, we welcome the ‘United Nations system common position supporting the implementation of 
the international drug control policy through effective inter-agency collaboration’ – in which the United 
Nations System Chief Executives Board for Coordination (UN CEB) makes a collective commitment to ‘call for 
changes in laws, policies and practices that threaten the health and human rights of People’ and to ‘promote 
alternatives to conviction and punishment in appropriate cases, including the decriminalization of drug 
possession for personal use’. The UN System Coordination Task Team, established to implement this UN 
common position, is also a positive development, and the strong contribution made today titled “What we 
have learned over the last ten years: A summary of knowledge acquired and produced by the UN system on 
drug-related matters” brings the crucial experience and expertise from across the UN family to bear on the 
often siloed drug policy debates at the CND. We congratulate the United Nations Secretary General on his 
leadership in promoting and consolidating UN system-wide coherence for drug policies. The continued 
engagement of UN agencies such as the Office of the High Commissioner for Human Rights, the Human Rights 
Council and its special procedures, human rights treaty bodies, the World Health Organization, the UN 
Development Programme, UNAIDS and others throughout the Ministerial Segment preparations has greatly 
contributed to this goal, and we call on member states to continue to promote their strong engagement 
beyond 2019.  
 
Similarly, we welcome the inclusion, in the Ministerial Declaration, of the commitment ‘to strengthen 
international and inter-agency cooperation’ and ‘enhance coherence within the United Nations system at all 
levels with regard to the World Drug Problem’. In addition, the Declaration includes references to human 
rights obligations and the SDGs – although such wording was significantly toned down in the negotiations 
process due to push back from more conservative governments. The result is a reiteration of already agreed 
general wording around both human rights and development, rather than a strong commitment to respect, 
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protect and fulfil human rights and fundamental freedoms, or to advance development in all aspects of drug 
policy, for the next decade. The fact that the Declaration does not explicitly include a specific target aimed at 
significantly reducing violations of human rights committed in the name of drug control or combatting 
impunity in the coming decade is a grave omission. Nonetheless, it is a positive step forward that the 
Declaration includes new targets focusing on improving the availability of controlled medicines, on promoting 
alternatives to conviction and punishment, and on increasing access to harm reduction services.  
 
Thirdly, we recommended that the discussions at the Ministerial Segment should reflect the realities of drug 
policy developments on the ground. This includes meaningful discussions on the implications of regulated 
cannabis markets emerging in multiple jurisdictions across the world, but also the need to discuss the 
egregious human rights violations resulting from repressive drug policies, including extrajudicial and other 
killings, the death penalty, disproportionate sentences, over-incarceration and the denial of harm reduction 
services that can save lives. This is particularly critical as various countries currently face an unprecedented 
overdose death crisis.  
 
Although some discussions have indeed – and for the first time – taken place on legal regulation, these mainly 
consisted in strong condemnations from some member states, rather than a meaningful debate on the way 
forward and how to manage the resulting tensions with the UN drug control treaties. Furthermore, and as was 
the case in 2016, the Ministerial Declaration fails to reflect the realities on the ground in a forward-looking, 
progressive manner.   
 
Finally, we recommended ending punitive approaches towards vulnerable groups and individuals – as is 
recommended both by the UN CEB and by the latest UNAIDS report ‘Health, rights and drugs: harm reduction, 
decriminalization and zero discrimination for people who use drugs’. The disproportionate impacts of punitive 
drug policies on specific communities – including women and ethnic minorities – were also highlighted today 
by the UN Working Group on the issue of discrimination against women in law and in practice and the UN 
Working Group of Experts on People of African Descent.  
 
Ending punitive approaches towards those most vulnerable will require that global drug control going forward 
puts people and communities at the centre, and seeks to improve their living conditions, address their 
situations of vulnerability and protect their human rights, in line with the SDG vision of ‘leaving no one behind’.  
 
In this regard, the powerful and diverse contributions from civil society – under the leadership of the Civil 
Society Task Force – have brought the realities from the ground directly to the fore, and have permitted 
member states to reflect on the impacts of punitive measures against those most affected. For this reason, 
the OHCHR concluded that ‘the participation of civil society organizations should be encouraged and their 
capacities strengthened in order to implement the joint commitments of the outcome document’, and that 
they ‘should be protected from any intimidation, threat, harassment or reprisal’. But there again, the 
Ministerial Declaration only partially incorporated these critical issues in its ‘Stock Taking’ section. 
 
As the UN meets today in Vienna to congratulate themselves on the adoption of yet another fraught 
consensus-based declaration on drug control, it will once again be up to civil society to hold our 
governments accountable for the choices they make in drug control, and to continue to bring the realities 
from affected groups and communities to promote an approach that truly respects human rights, protects 
health and social inclusion, and fosters development, peace and security. This, however, will require that 
governments finally admit that it is repressive drug policies themselves which are the main driver of the 
devastating harms associated with drugs. 
 
 
